Health systems across the country are making it easier for primary care clinicians to order genetic tests for patients who ...

Myriad Genetics, Inc. (MYGN), a genetic and genomic tumor testing and precision medicine provider, and INTERLINK Care Management, ...

SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and INTERLINK Care Management, Inc.

Ameera Shah-led Metropolis Healthcare Limited, Indias second-largest and most respected pathology laboratory chain, today ...

Mallards over the 30 percent farm-raised DNA threshold are showing poor migration habits The author's drake mallard and three ...

Molecular profiling and genetic testing have revolutionised lung cancer treatment, says a doctor. They have enabled targeted therapies that are more effective and tolerable than traditional ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

A new study suggests clinical utility of the first FDA-approved genetic test to help gauge an individual’s risk for opioid ...

The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.

A bill is moving through the Wyoming Legislature to give access to post-conviction DNA testing to more Wyoming felons. The ...

A set of Colorado Senators are demanding extra oversight of the Colorado Bureau of Investigation after discoveries of 500-day ...

Over a year after a dead 15-foot shark was found with mysterious bite wounds and stripped of its internal organs, DNA ...